Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in &lt;i&gt;LMNA&lt;/i&gt; Mutation-Induced Dilated Cardiomyopathy. This evidence concerns the gene LOXL2 and cardiomyopathy.